AMG National Trust Bank Raises Stake in UnitedHealth Group Incorporated $UNH

AMG National Trust Bank increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the second quarter, according to its most recent filing with the SEC. The fund owned 14,927 shares of the healthcare conglomerate’s stock after buying an additional 152 shares during the quarter. AMG National Trust Bank’s holdings in UnitedHealth Group were worth $4,657,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP lifted its holdings in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock valued at $4,257,131,000 after purchasing an additional 196,696 shares during the last quarter. Nuveen LLC purchased a new stake in UnitedHealth Group during the first quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after purchasing an additional 847,054 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on UNH shares. The Goldman Sachs Group started coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target on the stock. Bank of America upped their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Truist Financial upped their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Finally, Jefferies Financial Group upped their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Stock Down 3.0%

UNH stock opened at $344.57 on Friday. The stock has a market cap of $312.07 billion, a price-to-earnings ratio of 17.98, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company’s 50 day moving average is $342.82 and its 200 day moving average is $331.10. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $7.15 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.